SCH 503034
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SCH 503034, covering 2011-06-15 to 2011-06-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523) [Phase 2]